Rothschild Investment LLC Has $870,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Rothschild Investment LLC boosted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 9,655 shares of the exchange traded fund’s stock after purchasing an additional 282 shares during the quarter. Rothschild Investment LLC’s holdings in SPDR S&P Biotech ETF were worth $870,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. IFP Advisors Inc boosted its position in shares of SPDR S&P Biotech ETF by 68.0% during the fourth quarter. IFP Advisors Inc now owns 4,317 shares of the exchange traded fund’s stock worth $389,000 after purchasing an additional 1,747 shares in the last quarter. Wealth Alliance raised its stake in SPDR S&P Biotech ETF by 4.4% during the 4th quarter. Wealth Alliance now owns 4,083 shares of the exchange traded fund’s stock worth $368,000 after buying an additional 173 shares during the period. Bank of Jackson Hole Trust bought a new position in SPDR S&P Biotech ETF during the fourth quarter worth about $43,000. Key Financial Inc grew its stake in SPDR S&P Biotech ETF by 52.2% in the fourth quarter. Key Financial Inc now owns 1,166 shares of the exchange traded fund’s stock valued at $105,000 after acquiring an additional 400 shares during the period. Finally, Atria Wealth Solutions Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 24.1% in the fourth quarter. Atria Wealth Solutions Inc. now owns 14,548 shares of the exchange traded fund’s stock worth $1,310,000 after acquiring an additional 2,822 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

NYSEARCA XBI opened at $90.11 on Tuesday. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47. The firm has a market cap of $6.87 billion, a P/E ratio of 11.47 and a beta of 1.11. The stock’s 50-day moving average is $91.26 and its 200-day moving average is $95.97.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.